NATURAL PRODUCT RESEARCH AND DEVELOPMENT ›› 2022, Vol. 34 ›› Issue (6): 996-1004.doi: 10.16333/j.1001-6880.2022.6.012

Previous Articles     Next Articles

8-O-Acetylharpagide induces apoptosis of colon cancer HCT116 cells through Wnt signaling pathway

ZHOU Xing,YIN Qian,HUANG Rong,JIAN Bin,CAI Xiao-ming*   

  1. Innovation Lab of College of Basic Medicine,North Sichuan Medical College,Nanchong 637100,China
  • Online:2022-06-28 Published:2022-06-30

Abstract:

In this study,we investigated the effect and molecular mechanism of 8-O-acetylharpagide in colon cancer.Human colon cancer line HCT116 cell cycle was blocked in G1 phase after 8-O-acetylharpagide treatment.In addition,0.75 mmol/L 8-O-acetylharpagide significantly increased apoptosis of HCT116 cells.The whole transcriptome sequencing analysis showed that 8-O-acetylharpagide caused a total of 1 921 up-regulated mRNAs and 2 208 down-regulated mRNAs in HCT116 cells,and Wnt signaling pathway-related genes transcription level changed significantly.In cellular experiments in vitro,8-O-acetylharpagide treatment led to significant down-regulation of β-catenin,CyclinD1,Survivin,c-Myc and Bcl-2,while significant up-regulation of proapoptotic proteins Bax and cleaved-caspase3.Together,these results suggest that 8-O-acetylharpagide inhibit the proliferation and induce apoptosis of colon cancer cells mainly through Wnt signaling pathway.

Key words: 8-O-acetylharpagide, Wnt signaling pathway, colon cancer, apoptosis

CLC Number: